Abstract: Among others, the present invention provides for beta-hydroxybutyrate (e.g., R—BHB) acids and/or salts with pure biobased carbon content (e.g., 100% as measured by Carbon-14 analysis). The present invention also provides methods for preparing beta-hydroxybutyrate (e.g., R—BHB) acid and salt with pure biobased carbon content, comprising chemical synthesis and/or biosynthesis process. For instance, the method may include biological fermentation, and/or bioenzymatic process.

Abstract: An Aspergillus oryzae and its application belong to the field of microbiology and food processing technology. The present application, on the one hand, provides an Aspergillus oryzae (WZ-212), on the other hand, provides this Aspergillus oryzae in application of enhancing the inhibitory activity of ?-glucosidase by grapefruit peel and the method of application. Using the Aspergillus oryzae of this application to treat grapefruit peel, the inhibition of ?-glucosidase activity by grapefruit peel extract was significantly enhanced, and the process is simple, low cost, which is easy to achieve industrial production.

Abstract: The invention relates to a Novosphingobium sp. SJB007 and an application thereof in removal of phosphorus from wastewater, belonging to the technical field of environmental microorganisms. One aspect of the invention provides a Novosphingobium sp. SJB007 with an access number of CGMCC (China General Microbiological Culture Collection Center) No. 21177. Another aspect of the invention provides an application of the Novosphingobium sp. SJB007 in removal of phosphorus from wastewater. The efficient phosphorus-accumulating strain Novosphingobium sp. SJB007 provided by the invention has a high removal rate of more than 97% when the concentration of phosphorus in the wastewater is 10-30 mg/L under an appropriate condition.

Abstract: A substrate includes a base, a pixel defining layer, a plurality of electrode pairs, and a plurality of light-emitting devices. The pixel defining layer is disposed on the base, and includes a plurality of through holes. At least one electrode pair includes a first electrode and a second electrode that are disposed at least on a hole wall of one of the through holes and at least partially opposite to each other, and the first electrode and the second electrode are insulated from each other. One of the plurality of light-emitting devices includes a liquid functional layer disposed in the through hole. The liquid functional layer is in direct contact with the first electrode and the second electrode. The liquid functional layer includes a liquid light-emitting layer configured to emit light.

Abstract: A process of making Roxadustat of the following formula: comprising converting a compound of formula VI: to Roxadustat, wherein R is a C1-C20 alkyl group, and PG is a protective group.

Abstract: Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.

Abstract: Mechanisms are provided for a user equipment (UE) to determine to use a shared resource such as an antenna to access a land based wireless communication system or a satellite communication system. The UE can provide a first priority indication to indicate whether to access the land based wireless communication system based on one or more wireless link metrics of the land based wireless communication system or one or more application metrics for applications using the land based wireless communication system; and provide a second priority indication to indicate whether to access the satellite wireless communication system based on one or more service metrics provided by the satellite wireless communication system. The UE can determine to use the shared resources to access the land based wireless communication system or the satellite communication system based on the first priority indication and the second priority indication.

Abstract: An electronic device receives an indication of a number of physical resource blocks and subcarrier spacing of at least a portion of a transmission channel and determines a dynamic transmission bandwidth, or receives an indication of a modulation coding scheme of the transmission channel and determines a modulation order. The electronic device transmits, using a transmitter, a signal over at least the portion of the transmission channel based on the dynamic transmission bandwidth being less than or equal to a threshold bandwidth, or the modulation order not corresponding to an additional power backoff, using a first power based on a maximum output power capacity of the electronic device and a maximum power reduction. Otherwise, the electronic device transmits the signal over at least the portion of the transmission channel at a second power based on the maximum output power capacity, the maximum power reduction and the additional power backoff.

Abstract: Provided are an oxazino-quinazoline and oxazino-quinoline type compound, a preparation method, and uses thereof. More particularly provided is a compound shown in formula (I), an isomer, a hydrate, a solvate, a pharmaceutically acceptable salt, a prodrug thereof, a preparation method, and uses thereof in preparing a drug acting as a kinase inhibitor.

Abstract: A method includes receiving an indication to transmit a first set of signals using a first standard (e.g., Long Term Evolution) via a first set of antennas of a radio frequency device and a second set of signals using a second standard (e.g., New Radio) via a second set of antennas. The method also includes transmitting the first set of signals via the first set of antennas using a first power based on positions of the first set and second set of antennas, exposure conditions of the first set and the second set of signals on a user, and/or priorities of the first and the second set of signals. Moreover, the method includes transmitting the second set of signals via the second set of antennas using a second power based on the positions of the antennas, the exposure conditions of the signals on the user, and/or priorities of the signals.

Abstract: A device, system and method for a user equipment (UE) to report a network resource and capability state to a network for coordinating network resource allocations. The UE is configured to establish a first connection to a first network based on a first subscriber identity module (SIM) of the UE and further configured to establish a second connection to a second network based on a second SIM of the UE. The method includes determining an upcoming first change of a state of the UE with respect to the first connection and transmitting, to the first network, an indication of the first change of state of the UE. The method further includes changing the state of the UE with respect to the first connection.

Abstract: The invention relates to a Novosphingobium sp. SJB007 and an application thereof in removal of phosphorus from wastewater, belonging to the technical field of environmental microorganisms. One aspect of the invention provides a Novosphingobium sp. SJB007 with an access number of CGMCC (China General Microbiological Culture Collection Center) No. 21177. Another aspect of the invention provides an application of the Novosphingobium sp. SJB007 in removal of phosphorus from wastewater. The efficient phosphorus-accumulating strain Novosphingobium sp. SJB007 provided by the invention has a high removal rate of more than 97% when the concentration of phosphorus in the wastewater is 10-30 mg/L under an appropriate condition.

Abstract: The present invention relates to an urea-substituted aromatic ring-linked dioxinoquinoline compound of formula (I), or a pharmaceutically acceptable salt or a hydrate thereof. The invention also provides a preparation method of the compound of formula (I) and a pharmaceutically acceptable salt thereof, as well as uses thereof as a drug, wherein the drug acting as a tyrosine kinase (i.e. VEGFR-2, C-RAF, B-RAF, and RET) inhibitor is used for treating disorders related to tyrosine kinase.

Abstract: Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a dioxinoquinoline compound of formula (I) or a pharmaceutically acceptable salt thereof. The invention also provides a preparation method of the compound of formula (I) and a pharmaceutically acceptable salt thereof, as well as uses thereof as a drug, wherein the drug acting as a tyrosine kinase (i.e. VEGFR-2 and c-MET) inhibitor is used for treating disorders related to tyrosine kinase.

Abstract: The present invention relates to a scalable process for the making of elagolix, its salts and the process of intermediate compounds.

Abstract: Disclosed are an image data reading method and apparatus, an electronic device, and a readable storage medium, relating to the technical field of LED image display. The image data reading method includes: storing image data in each row of image blocks into a number of v storage blocks, where each of the v storage blocks stores a number of h rows, each row of data including image data stored at a same position of each group in a same row of every image block; and sequentially outputting from each of the v storage blocks by: sequentially reading each row of the image data in a vertical order, and simultaneously outputting the image data stored at the same position.

Abstract: A wireless communication device (UE) may conduct wireless communications using one or more antennas according to multiple radio access technologies (RAT) associated with corresponding operating frequency bands. The UE may perform adaptive antenna tuning, for example, application-based antenna tuning for increasing the operating efficiency of the UE, which may improve user experience. The UE may periodically identify one or more applications running on the UE, the respective RATs that support the (running) applications, and which of the corresponding frequency bands are used by the (running) applications. The UE may determine the tuner device settings for tuning the one or more antenna(s) based on the (running) applications or the type and/or priority of the (running) applications, which RATs support the running applications, which of the corresponding frequency bands are used by the (running) applications, and operating conditions associated with the frequency bands used by the (running) applications.

Abstract: Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a scalable process for the making of elagolix, its salts and the process of intermediate compounds.